Stop Loss for Gene Therapy
May 22, 2025
Brent welcomes Tye Rambo, Stop Loss Business Strategy Manager, to discuss how Elevance Health is helping employers manage the financial risks of high-cost gene therapies. With one-time treatments ranging from $850,000 to over $3 million, Tye explains how Elevance’s stop loss solution ensures consistent coverage by avoiding “lasering”—a tactic that raises deductibles for known high-cost claimants. Their No New Laser protection ensures clients have predictable risk protection as groundbreaking therapies emerge. A concise, critical breakdown of how smart stop loss design can shield employer budgets while ensuring member access to life-changing treatments.
